Cell Tissue Engineering and the Lung
A special issue of Journal of Functional Biomaterials (ISSN 2079-4983).
Deadline for manuscript submissions: closed (1 December 2022) | Viewed by 2952
Special Issue Editors
Interests: corneal wound healing; cornea trauma; keratoconus; bioengineering; bioprinting; diabetic keratopathy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cell tissue engineering approaches can be used to regenerate damaged organs or even replace dysfunctional ones. The lung is an organ that primarily functions to transport oxygen into the blood and remove carbon dioxide. Many lung diseases may initially limit patient functional activity and can ultimately lead to respiratory failure and death. Current medications have limited efficacy for common disorders such as emphysema and pulmonary fibrosis. In the United States, approximately 2500 adults receive lung transplants each year. Due to limitations in donor availability and suboptimal outcomes, many more suffer the effects of lung disease or die without lung transplant. The one-year survival in the US is 86.7%, and the five-year survival is 52.5%.
Current developments in biomaterials and/or cell tissue engineering involve the use of cell culture on three-dimensional scaffolds, highlighting the importance of extracellular matrix composition and how it can modulate lung compliance and limit its ability to expand and ventilate effectively. Other technologies include the investigation of 3D printing technologies, hybrid biomaterials, biomechanical cues, mechanobiology, and tissue engineering—all necessary to achieve the ultimate goals of in vivo effectiveness.
We invite you to contribute your work to this Special Issue of JFB on “Cell tissue engineering and the lung”. We welcome full articles, short communications, or reviews to highlight all the recent findings that have broadened lung-related horizons, including, but not limited to, the availability of new bioprinting approaches; technological advancements of established techniques or processes; progress in cell and tissue engineering; the translation of technologies from bench to bedside; and achievements in the clinical and regulatory field.
Prof. Dr. Dimitrios Karamichos
Dr. Alan Betensley
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell tissue engineering
- biomaterials
- lung
- bioprinting
